Quantcast
Last updated on April 16, 2014 at 7:58 EDT

Latest ophthalmic solution Stories

2011-11-09 07:00:00

IRVINE, Calif., Nov. 9, 2011 /PRNewswire/ -- Emmy®-nominated actress Christina Hendricks, in partnership with Allergan, Inc. (NYSE: AGN), the maker of LATISSE® (bimatoprost ophthalmic solution) 0.03% is calling on women to help her in a final push to raise $500,000 for the Make-A-Wish Foundation by November 30 through the LATISSE® Wishes Challenge - a campaign inspired by the tradition of blowing on an eyelash to make wishes come true....

2011-06-07 08:00:00

IRVINE, Calif., June 7, 2011 /PRNewswire/ -- Allergan, Inc. (NYSE: AGN), the maker of LATISSE® (bimatoprost ophthalmic solution) 0.03%, announced today the launch of the 2011 LATISSE® Wishes Challenge. Inspired by the tradition of blowing on an eyelash to make wishes come true, the campaign is gaining momentum for the second year by rallying women in support of the Make-A-Wish Foundation®, a nonprofit organization dedicated to granting...

2008-07-03 09:01:19

FDC has received approval from the FDA for its abbreviated new drug application, Ciprofloxacin ophthalmic solution. FDC's Ciprofloxacin Ophthalmic Solution is a broad spectrum antibiotic used for occular surface infections. The company has recently received approval for Timolol maleate ophthalmic solution. Another abbreviated new drug application Ofloxacin ophthalmic solution is in the final stages of approval.